AWM
AURA icon

Avior Wealth Management’s Aura Biosciences AURA Stock Holding History

Avior Wealth Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4
Closed -$31 – 2385
2024
Q1 		$31 Buy
+4
New +$33 ﹤0.01% 3594

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Avior Wealth Management's AURA Position: Q2 2024 in Review

Avior Wealth Management sold out of Aura Biosciences (AURA) in Q2 2024, closing a stake of 4 shares — an estimated $31 sold.

Avior Wealth Management first reported a position in AURA in Q1 2024 and held it in 1 quarter. The position peaked at $31 in Q1 2024. 75 funds tracked by Wall St. Rank hold AURA as of Q2 2024.

  • Avior Wealth Management reported no remaining Aura Biosciences position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 4 Aura Biosciences shares in Q2 2024, an estimated $31.
  • Avior Wealth Management first reported a position in Aura Biosciences in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's Aura Biosciences position peaked at $31 in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.